Stay updated on Expanded Access to Upadacitinib Clinical Trial

Sign up to get notified when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Expanded Access to Upadacitinib Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-01T03:58:26.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed information about an expanded access program for upadacitinib and its eligibility criteria, while adding references to Crohn Disease and a new version revision.
    Difference
    9%
    Check dated 2025-04-16T14:31:12.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page now indicates that a study is available, with updated contact information for the ABBVIE Call Center, and the revision has been updated to v2.14.4. Previous dates and the indication of unavailability have been removed.
    Difference
    3%
    Check dated 2025-04-09T09:21:04.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect new information regarding Crohn disease and its treatment with upadacitinib, replacing previous references to atopic dermatitis and its treatment. Additionally, the update includes new dates and a shift in the form of medication from an oral tablet to an oral solution.
    Difference
    7%
    Check dated 2025-03-11T04:40:30.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    3%
    Check dated 2025-02-24T21:07:38.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    3%
    Check dated 2025-02-10T09:54:04.000Z thumbnail image

Stay in the know with updates to Expanded Access to Upadacitinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.